\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ nonpalpable\\,\\ nontender\\ thyroid\\ gland\\.\ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ tsh\\ of\\ 0\\.08\\ uiu\\/ml\\,\\ and\\ free\\ t4\\ of\\ 63\\.8\\ pmol\\/l\\.\\ \\ \ \(0\)\
\-\ the\\ 25\\-hr\\ raiu\\ \\=\\ \\ 0\\.9\\ \\%\\ \\(normal\\ 8\\ \\-\\ 30\\%\\)\\.\ \(0\)\
\-\ amiodarone\\ was\\ discontinued\\ and\\ methimazole\\ was\\ initiated\\.\ \(0\)\
\-\ absent\\ uptake\\ within\\ the\\ thyroid\\ and\\ decreased\\ 24\\-hour\\ radioactive\\ iodine\\ uptake\\.\\ \\ findings\\ consistent\\ with\\ amiodarone\\ induced\\ hyperthyroidism\\.\ \(0\)\
\-\ amiodarone\\ induced\\ thyroiditis\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ factitious\\ hyperthyroidism\\ \\(thyroid\\ hormone\\ supplementation\\)\ \(0\)\
\-\ struma\\ ovari\\ \\(ovarian\\ carcinoma\\)\ \(0\)\
\-\ jod\\ basedow\\ phenomenon\ \(0\)\
\-\ 90\\ year\\ old\\ female\\ with\\ history\\ of\\ tremors\\,\\ lower\\ extremity\\ edema\\ and\\ insomnia\\.\\ \\ she\\ has\\ a\\ history\\ of\\ hyperthyroidism\\ and\\ amiodarone\\ use\\.\ \(0\)\
\-\ two\\ types\\ of\\ hyperthyroidism\\ related\\ to\\ amiodarone\\ may\\ occur\\.\\ \\ type\\ i\\ \\(iodine\\-induced\\ hyperthyroidism\\)\\ and\\ type\\ ii\\ \\(destructive\\ thyrotoxicosis\\)\\.\\ \\ type\\ i\\ often\\ has\\ low\\ raiu\\ \\(but\\ the\\ raiu\\ may\\ be\\ normal\\ or\\ rarely\\ elevated\\)\\;\\ and\\ this\\ type\\ often\\ responds\\ to\\ antithyroid\\ medications\\.\\ \\ type\\ ii\\ always\\ presents\\ with\\ low\\ raiu\\ and\\ is\\ typically\\ responsive\\ to\\ glucocorticoids\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amiodarone\\:\\ 0\\.18608380945635578\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.1577051873703477\ \(0\)\
\-\ raiu\\:\\ 0\\.1341961015954299\ \(0\)\
\-\ type\\:\\ 0\\.0823035493813403\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.061503213936929736\ \(0\)\
\-\ thyroid\\:\\ 0\\.060039641912995045\ \(0\)\
\-\ induced\\:\\ 0\\.05859015965545785\ \(0\)\
\-\ nonpalpable\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ 63\\.8\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ 25\\-hr\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\-subacute\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\-factitious\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\-jod\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ iodine\\-induced\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ antithyroid\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\-struma\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ ovari\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ basedow\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ pmol\\/l\\:\\ 0\\.042452708930552044\ \(0\)\
\-\ methimazole\\:\\ 0\\.042452708930552044\ \(0\)\
\-\ ii\\:\\ 0\\.04212136810335343\ \(0\)\
\-\ i\\:\\ 0\\.04036931080261154\ \(0\)\
\-\ uptake\\:\\ 0\\.03879981056793385\ \(0\)\
\-\ tremors\\:\\ 0\\.038491867898780924\ \(0\)\
\-\ responds\\:\\ 0\\.037818821980744446\ \(0\)\
\-\ 0\\.08\\:\\ 0\\.037216761891271155\ \(0\)\
\-\ insomnia\\:\\ 0\\.037216761891271155\ \(0\)\
\-\ supplementation\\:\\ 0\\.0366721322923893\ \(0\)\
\-\ 24\\-hour\\:\\ 0\\.03617492442387713\ \(0\)\
\-\ 0\\.9\\:\\ 0\\.03571753752288549\ \(0\)\
\-\ thyrotoxicosis\\:\\ 0\\.03571753752288549\ \(0\)\
\-\ glucocorticoids\\:\\ 0\\.0352940633962928\ \(0\)\
\-\ uiu\\/ml\\:\\ 0\\.034899818416367356\ \(0\)\
\-\ discontinued\\:\\ 0\\.034899818416367356\ \(0\)\
\-\ radioactive\\:\\ 0\\.03418460045663018\ \(0\)\
\-\ responsive\\:\\ 0\\.032457281188784846\ \(0\)\
\-\ phenomenon\\:\\ 0\\.03198081485199027\ \(0\)\
\-\ often\\:\\ 0\\.031159697697367456\ \(0\)\
\-\ iodine\\:\\ 0\\.030751606968464868\ \(0\)\
\-\ initiated\\:\\ 0\\.03005811635701191\ \(0\)\
\-\ destructive\\:\\ 0\\.029295079827728925\ \(0\)\
\-\ t4\\:\\ 0\\.028622033909692448\ \(0\)\
\-\ hormone\\:\\ 0\\.027687008630939296\ \(0\)\
\-\ low\\:\\ 0\\.02715620631847314\ \(0\)\
\-\ tsh\\:\\ 0\\.02652074945183349\ \(0\)\
\-\ \\=\\:\\ 0\\.02562734333531524\ \(0\)\
\-\ always\\:\\ 0\\.025123873235256573\ \(0\)\
\-\ nontender\\:\\ 0\\.025055437857846766\ \(0\)\
\-\ types\\:\\ 0\\.024920977872645658\ \(0\)\
\-\ \\(\\:\\ 0\\.024766687756932363\ \(0\)\
\-\ \\)\\:\\ 0\\.024464149443884746\ \(0\)\
\-\ rarely\\:\\ 0\\.023411540300979448\ \(0\)\
\-\ 90\\:\\ 0\\.023017295321054013\ \(0\)\
\-\ \\%\\:\\ 0\\.02278081180966866\ \(0\)\
\-\ ovarian\\:\\ 0\\.022344249403017536\ \(0\)\
\-\ medications\\:\\ 0\\.021780412102977365\ \(0\)\
\-\ may\\:\\ 0\\.021420895644549985\ \(0\)\
\-\ absent\\:\\ 0\\.02116303220348546\ \(0\)\
\-\ gland\\:\\ 0\\.02079639252224382\ \(0\)\
\-\ related\\:\\ 0\\.02015572224726836\ \(0\)\
\-\ free\\:\\ 0\\.020098291756676923\ \(0\)\
\-\ use\\:\\ 0\\.01929965208596173\ \(0\)\
\-\ 30\\:\\ 0\\.018777653351171857\ \(0\)\
\-\ has\\:\\ 0\\.018339428234220318\ \(0\)\
\-\ occur\\:\\ 0\\.01832026645018022\ \(0\)\
\-\ 8\\:\\ 0\\.018257814618567705\ \(0\)\
\-\ extremity\\:\\ 0\\.017858051255099646\ \(0\)\
\-\ typically\\:\\ 0\\.01723671868289127\ \(0\)\
\-\ labs\\:\\ 0\\.016982708611057933\ \(0\)\
\-\ elevated\\:\\ 0\\.01656752206490893\ \(0\)\
\-\ normal\\:\\ 0\\.015309856623989726\ \(0\)\
\-\ decreased\\:\\ 0\\.014518608015568911\ \(0\)\
\-\ two\\:\\ 0\\.013984749929234317\ \(0\)\
\-\ carcinoma\\:\\ 0\\.013839586685804952\ \(0\)\
\-\ edema\\:\\ 0\\.013810991368178805\ \(0\)\
\-\ she\\:\\ 0\\.013707349379738127\ \(0\)\
\-\ history\\:\\ 0\\.01348816614522381\ \(0\)\
\-\ \\:\\:\\ 0\\.012917426468464744\ \(0\)\
\-\ physical\\:\\ 0\\.01198003011189279\ \(0\)\
\-\ consistent\\:\\ 0\\.011973132964749732\ \(0\)\
\-\ \\;\\:\\ 0\\.01157383536258625\ \(0\)\
\-\ was\\:\\ 0\\.011294600253870706\ \(0\)\
\-\ lower\\:\\ 0\\.010982068967793501\ \(0\)\
\-\ exam\\:\\ 0\\.010727051085425932\ \(0\)\
\-\ \\-\\:\\ 0\\.010467019764047791\ \(0\)\
\-\ but\\:\\ 0\\.0104143045773345\ \(0\)\
\-\ findings\\:\\ 0\\.01039335391879977\ \(0\)\
\-\ female\\:\\ 0\\.01003863012255905\ \(0\)\
\-\ presents\\:\\ 0\\.009975110260045291\ \(0\)\
\-\ within\\:\\ 0\\.009315036619349038\ \(0\)\
\-\ and\\:\\ 0\\.00822898311918713\ \(0\)\
\-\ be\\:\\ 0\\.007530038419108167\ \(0\)\
\-\ to\\:\\ 0\\.0073211675733083365\ \(0\)\
\-\ or\\:\\ 0\\.005722987136935471\ \(0\)\
\-\ this\\:\\ 0\\.0054922126475093315\ \(0\)\
\-\ year\\:\\ 0\\.005463458681559513\ \(0\)\
\-\ old\\:\\ 0\\.004999626267784312\ \(0\)\
\-\ \\,\\:\\ 0\\.0046407439802963555\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ is\\:\\ 0\\.0032130901621984322\ \(0\)\
\-\ \\.\\:\\ 0\\.0024342539038180303\ \(0\)\
\-\ the\\:\\ 0\\.0023699877377764424\ \(0\)\
\-\ a\\:\\ 0\\.0022662845818205786\ \(0\)\
\-\ with\\:\\ 0\\.002005785875826681\ \(0\)\
